Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants

作者: Krizelle Mae M. Alcantara , Joshua Reginald P. Malapit , Ryan Timothy D. Yu , Jose Antonio Ma. G. Garrido , John Paul T. Rigor

DOI: 10.3390/CELLS8121557

关键词: ETS transcription factor familyCancer researchEpidermal growth factor receptorNeuroblastoma RAS viral oncogene homologOncogeneSignal transductionKRASELK1CarcinogenesisBiology

摘要: RAS oncogene family members are molecular switches of signaling pathways that control cell growth, proliferation, differentiation, and survival. In colorectal cancer, Kirsten-RAS (KRAS) neuroblastoma-RAS (NRAS) the commonly mutated isoforms. Activating mutations in result cellular transformation independent upregulated epidermal growth factor receptor (EGFR)-initiated signaling. The present study characterized functional consequences non-canonical/novel KRAS NRAS mutants identified a targeted next-generation sequencing cancer specimens from Filipino patients. vitro assays NIH3T3 cells showed similar to canonical G12D mutant, overexpression G12S, A59T, Y137C, but not A11V, confer higher proliferation migration rates. HCT116 transfected with novel A11V G12D, mutants, display enhanced resistance apoptosis. All four induce gross changes F-actin cytoskeletal organization morphology cells. Only G12S A59T appear deregulate extracellular signal-regulated kinase (ERK) its downstream target ETS transcription ELK1 (ELK1). Elucidation differential effector engagement responsible for variable phenotypic readouts is warranted. If validated by mouse studies clinical correlates, these can have wider implications choosing treatment options.

参考文章(48)
Catherine D. Nobes, Alan Hall, Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement Journal of Cell Biology. ,vol. 144, pp. 1235- 1244 ,(1999) , 10.1083/JCB.144.6.1235
Yuliya Pylayeva-Gupta, Elda Grabocka, Dafna Bar-Sagi, RAS oncogenes: weaving a tumorigenic web Nature Reviews Cancer. ,vol. 11, pp. 761- 774 ,(2011) , 10.1038/NRC3106
Mahmut Yilmaz, Gerhard Christofori, EMT, the cytoskeleton, and cancer cell invasion Cancer and Metastasis Reviews. ,vol. 28, pp. 15- 33 ,(2009) , 10.1007/S10555-008-9169-0
Christin E. Burd, Wenjin Liu, Minh V. Huynh, Meriam A. Waqas, James E. Gillahan, Kelly S. Clark, Kailing Fu, Brit L. Martin, William R. Jeck, George P. Souroullas, David B. Darr, Daniel C. Zedek, Michael J. Miley, Bruce C. Baguley, Sharon L. Campbell, Norman E. Sharpless, Mutation-Specific RAS Oncogenicity Explains NRAS Codon 61 Selection in Melanoma Cancer Discovery. ,vol. 4, pp. 1418- 1429 ,(2014) , 10.1158/2159-8290.CD-14-0729
Prateek Kumar, Steven Henikoff, Pauline C Ng, Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols. ,vol. 4, pp. 1073- 1081 ,(2009) , 10.1038/NPROT.2009.86
Sug Hyung Lee, Jong Woo Lee, Young Hwa Soung, Hong Sug Kim, Won Sang Park, Su Young Kim, Jong Heun Lee, Jik Young Park, Yong Gu Cho, Chang Jae Kim, Suk Woo Nam, Sang Ho Kim, Jung Young Lee, Nam Jin Yoo, BRAF and KRAS mutations in stomach cancer. Oncogene. ,vol. 22, pp. 6942- 6945 ,(2003) , 10.1038/SJ.ONC.1206749
Joanne L. Yu, Linda May, Vladimir Lhotak, Siranoush Shahrzad, Senji Shirasawa, Jeffrey I. Weitz, Brenda L. Coomber, Nigel Mackman, Janusz W. Rak, Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood. ,vol. 105, pp. 1734- 1741 ,(2005) , 10.1182/BLOOD-2004-05-2042
M. J. Smith, B. G. Neel, M. Ikura, NMR-based functional profiling of RASopathies and oncogenic RAS mutations. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 4574- 4579 ,(2013) , 10.1073/PNAS.1218173110
Antoine E. Karnoub, Robert A. Weinberg, Ras oncogenes: split personalities Nature Reviews Molecular Cell Biology. ,vol. 9, pp. 517- 531 ,(2008) , 10.1038/NRM2438
Elizabeth M. Petty, Cellular cancer markers American Journal of Medical Genetics. ,vol. 68, pp. 492- 493 ,(1997) , 10.1002/(SICI)1096-8628(19970211)68:4<492::AID-AJMG29>3.0.CO;2-M